Catalyst Wire Dossier Catalyst Wire Dossier

Iomab-B

null · Actinium Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Iomab-B, covering 2023-07-19 to 2023-07-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia [Phase 3]

See pricing